| |
 |
|
Class Information
Number: 536/28.6
Name: Organic compounds -- part of the class 532-570 series > Organic compounds (class 532, subclass 1) > Carbohydrates or derivatives > Nitrogen containing > N-glycosides, polymers thereof, metal derivatives (e.g., nucleic acids, oligonucleotides, etc.) > N-glycosides wherein the n is part of a five-membered hetero ring (e.g., selenazole nucleosides, pyrrole nucleosides, etc.)
Description: Compounds which are N-glycosides wherein the N of the N-glycoside moiety is part of a five-membered nitrogen containing hetero ring.
Sub-classes under this class:
Patents under this class:
| Patent Number |
Title Of Patent |
Date Issued |
| 7321033 |
3-B-D-ribofuranosylthiazolo [4,5-d] pyrimidine nucleosides and uses thereof |
Jan. 22, 2008 |
| 7282581 |
Oligonucleotide labeling reactants based on acyclonucleosides and conjugates derived thereof |
Oct. 16, 2007 |
| 7138377 |
Topoisomerase inhibitors |
Nov. 21, 2006 |
| 7105661 |
Process for manufacturing morpholino-nucleotides, and use thereof for the analysis of and labelling of nucleic acid sequences |
Sep. 12, 2006 |
| 7081526 |
Process for manufacturing morpholino-nucleotides, and use thereof for the analysis of and labelling of nucleic acid sequences |
Jul. 25, 2006 |
| 7078499 |
Nucleotide analogues comprising a reporter moiety and a polymerase enzyme blocking moiety |
Jul. 18, 2006 |
| 7074917 |
Method for purifying 5' -protected 2' -deoxypurine nucleosides |
Jul. 11, 2006 |
| 7022830 |
Hepatitis C virus codon optimized non-structural NS3/4A fusion gene |
Apr. 4, 2006 |
| 6960569 |
Hepatitis C virus non-structural NS3/4A fusion gene |
Nov. 1, 2005 |
| 6958391 |
Method for purifying 5'-protected 2'-deoxypurine nucleosides |
Oct. 25, 2005 |
| 6949639 |
Oligonucleotide labeling reactants and their use |
Sep. 27, 2005 |
| 6930093 |
Use of ribofuranose derivatives against inflammatory bowel diseases |
Aug. 16, 2005 |
| 6924270 |
Ribavirin-interferon alfa combination therapy for eradicating detectable HCV-RNA in patients having chronic hepatitis C infection |
Aug. 2, 2005 |
| 6867198 |
Agents and methods for the treatment of proliferative diseases |
Mar. 15, 2005 |
| 6858590 |
Vaccines containing ribavirin and methods of use thereof |
Feb. 22, 2005 |
| 6855698 |
Topoisomerase I selective cytotoxic sugar derivatives of indolopyrrolocarbazoles |
Feb. 15, 2005 |
| 6846918 |
Nucleoside modifications by palladium catalyzed methods |
Jan. 25, 2005 |
| 6838560 |
Process for manufacturing morpholino-nucleotides, and use thereof for the analysis of and labelling of nucleic acid sequences |
Jan. 4, 2005 |
| 6815542 |
Nucleoside compounds and uses thereof |
Nov. 9, 2004 |
| 6790837 |
Ribavirin syrup formulations |
Sep. 14, 2004 |
| 6784161 |
Method for the treatment or prevention of flavivirus infections using nucleoside analogues |
Aug. 31, 2004 |
| 6699979 |
Oligonucleotides having chiral phosphorus linkages |
Mar. 2, 2004 |
| 6660721 |
Anti-HCV nucleoside derivatives |
Dec. 9, 2003 |
| 6653290 |
Tumor proliferation inhibitors |
Nov. 25, 2003 |
| 6573248 |
Monocyclic L-nucleosides, analogs and uses thereof |
Jun. 3, 2003 |
| 6552183 |
Moncyclic L-nucleosides analogs |
Apr. 22, 2003 |
| 6518253 |
Treatment of viral infections using the L-isomer of ribavirin |
Feb. 11, 2003 |
| 6495677 |
Nucleoside compounds |
Dec. 17, 2002 |
| 6150337 |
Specific modulation of Th1/Th2 cytokine expression by Ribavirin in activated T-lymphocytes |
Nov. 21, 2000 |
| 6063772 |
Specific modulation of Th1/Th2 cytokine expression by ribavirin in activated T-lymphocytes |
May. 16, 2000 |
| 6030960 |
Method of treating hepatitis virus infections |
Feb. 29, 2000 |
| 5863903 |
Use of hydroxy alkyl piperidine and pyrrolidine compounds to treat diabetes |
Jan. 26, 1999 |
| 5843937 |
DNA-binding indole derivatives, their prodrugs and immunoconjugates as anticancer agents |
Dec. 1, 1998 |
| 5777100 |
AICA riboside analogs |
Jul. 7, 1998 |
| 5767097 |
Specific modulation of Th1/Th2 cytokine expression by ribavirin in activated T-lymphocytes |
Jun. 16, 1998 |
| 5721350 |
Deuterated nucleosides |
Feb. 24, 1998 |
| 5714599 |
Process for the preparation of ste specific 1'-spiro-nucleosides |
Feb. 3, 1998 |
| 5703093 |
Compounds and methods for the treatment of cardiovascular, inflammatory and immune disorders |
Dec. 30, 1997 |
| 5681947 |
Oligonucleotides having universal nucleoside spacers |
Oct. 28, 1997 |
| 5621086 |
Sialic acid derivative and method of manufacturing it |
Apr. 15, 1997 |
| 5545636 |
Protein kinase C inhibitors |
Aug. 13, 1996 |
| 5442051 |
Anhydrous crystal of 4-carbamoyl-1-.beta.-D-ribofuranosyl imidazolium-5-oleate |
Aug. 15, 1995 |
| 5438131 |
3-nitropyrrole nucleoside |
Aug. 1, 1995 |
| 5380746 |
Bis-(1H-indol-3-YL)-maleinimide derivatives, processes for the preparation thereof and pharmaceutical compositions containing them |
Jan. 10, 1995 |
| 5367062 |
Disubstituted and deoxydisubstituted derivatives of .alpha.-d-lyxofuranosides having anti-inflammatory and anti-proliferative activity |
Nov. 22, 1994 |
| 5324828 |
1-amino-1-deoxyoligosaccharides and derivatives thereof |
Jun. 28, 1994 |
| 5283175 |
Genus-specific oligomers of Borrelia and methods of using same |
Feb. 1, 1994 |
| 5268464 |
Process for the preparation of nucleosides |
Dec. 7, 1993 |
| 5218106 |
2',3'-dideoxy-2'-fluoronucleosides |
Jun. 8, 1993 |
| 5158938 |
Rebeccamycin |
Oct. 27, 1992 |
|
|
|
